Attenuation of Vanadium-Induced Neurotoxicity in Rat Hippocampal Slices (In Vitro) and Mice (In Vivo) by ZA-II-05, a Novel NMDA-Receptor Antagonist
Authors:
- Amany Digal LadaguAmany Digal Ladagu
- Funmilayo Eniola OlopadeFOFunmilayo Eniola Olopade
- Paul ChazotPaul Chazot
- Ademola A. OyagbemiAOAdemola A. Oyagbemi
- Samuel OhiomokhareSOSamuel Ohiomokhare
- Oluwabusayo Racheal FolarinOFOluwabusayo Racheal Folarin
- Taidinda Tashara GilbertTGTaidinda Tashara Gilbert
- Madison FullerMFMadison Fuller
- Toan LuongTLToan Luong
- Adeboye AdejareAAAdeboye Adejare
- James O. OlopadeJOJames O. Olopade
Open Access
- 24 November 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (23) , 16710
Abstract
Exposure to heavy metals, such as vanadium, poses an ongoing environmental and health threat, heightening the risk of neurodegenerative disorders. While several compounds have shown promise in mitigating vanadium toxicity, their efficacy is limited. Effective strategies involve targeting specific subunits of the NMDA receptor, a glutamate receptor linked to neurodegenerative conditions. The potential neuroprotective effects of ZA-II-05, an NMDA receptor antagonist, against vanadium-induced neurotoxicity were explored in this study. Organotypic rat hippocampal slices, and live mice, were used as models to comprehensively evaluate the compound’s impact. Targeted in vivo fluorescence analyses of the hippocampal slices using propidium iodide as a marker for cell death was utilized. The in vivo study involved five dams, each with eight pups, which were randomly assigned to five experimental groups (n = 8 pups). After administering treatments intraperitoneally over six months, various brain regions were assessed for neuropathologies using different immunohistochemical markers. High fluorescence intensity was observed in the hippocampal slices treated with vanadium, signifying cell death. Vanadium-exposed mice exhibited demyelination, microgliosis, and neuronal cell loss. Significantly, treatment with ZA-II-05 resulted in reduced cellular death in the rat hippocampal slices and preserved cellular integrity and morphological architecture in different anatomical regions, suggesting its potential in countering vanadium-induced neurotoxicity.Keywords
Funding Information
- International Society for Neurochemistry (ISN CAEN Category 1A/2016)
This publication has 73 references indexed in Scilit:
- Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s DiseaseNeurotoxicity Research, 2013
- NMDA Receptor Activity in Neuropsychiatric DisordersFrontiers in Psychiatry, 2013
- Identification of latent tuberculosis infection in rheumatic patients under consideration for treatment with anti-TNF-α agentsArchives of Medical Science, 2013
- Combination Therapy for Alzheimerʼs DiseaseDrugs & Aging, 2011
- TNF‐α‐mediates neuroprotection against glutamate‐induced excitotoxicity via NF‐κB‐dependent up‐regulation of KCa2.2 channelsJournal of Neurochemistry, 2008
- Bis(quercetinato)oxovanadium IV Reverses Metabolic Changes in Streptozotocin-Induced Diabetic MiceThe Review of Diabetic Studies, 2007
- Cholinergic function and Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2003
- The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug DevelopmentThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Diphenyl Diselenide and Ascorbic Acid Changes Deposition of Selenium and Ascorbic Acid in Liver and Brain of MiceBasic & Clinical Pharmacology & Toxicology, 2001
- Differential Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptor SubunitsJournal of Biological Chemistry, 1995